Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Quick

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Postgraduate Medicine|December 1, 1984
Use of anticoagulants. Therapy and prophylaxis for thromboembolic phenomenaD Quick, A A Trowbridge
Chest|November 1, 1985
Heparin: applications and future prospectsD Quick, A A Trowbridge
Mental Retardation|April 1, 1977
A model for preschool curriculum: project MEMPHISA D Quick, A A Campbell
Lancet (London, England)|January 22, 1994
Adaptation of WHO drug use indicators in hospitalJ D Quick, H M Thuo
Virology|October 1, 1990
Vaccinia virus gene D7R encodes a 20,000-dalton subunit of the viral DNA-dependent RNA polymeraseS D Quick, S S Broyles
Health Policy and Planning|February 13, 2003
Ten best readings in ... essential medicinesJonathan D Quick, Hans V Hogerzeil
Lancet (London, England)|April 16, 2013
Is Option B+ the best choice?Scott Kellerman, Jonathan S Jay, Jonathan D Quick
Pediatrics|October 1, 1972
Vaccinia virus and tuberculin reactivityE M Smithwick, M Steiner, J D Quick
BMC Health Services Research|August 29, 2014
Quality use of medicines within universal health coverage: challenges and opportunitiesAnita K Wagner, Jonathan D Quick, Dennis Ross-Degnan
Lancet (London, England)|January 6, 1990
Drug economics in developing countriesJ I Litvack, D S Shepard, J D Quick
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Postgraduate Medicine|December 1, 1984
Use of anticoagulants. Therapy and prophylaxis for thromboembolic phenomenaD Quick, A A Trowbridge
Chest|November 1, 1985
Heparin: applications and future prospectsD Quick, A A Trowbridge
Mental Retardation|April 1, 1977
A model for preschool curriculum: project MEMPHISA D Quick, A A Campbell
Lancet (London, England)|January 22, 1994
Adaptation of WHO drug use indicators in hospitalJ D Quick, H M Thuo
Virology|October 1, 1990
Vaccinia virus gene D7R encodes a 20,000-dalton subunit of the viral DNA-dependent RNA polymeraseS D Quick, S S Broyles
Health Policy and Planning|February 13, 2003
Ten best readings in ... essential medicinesJonathan D Quick, Hans V Hogerzeil
Lancet (London, England)|April 16, 2013
Is Option B+ the best choice?Scott Kellerman, Jonathan S Jay, Jonathan D Quick
Pediatrics|October 1, 1972
Vaccinia virus and tuberculin reactivityE M Smithwick, M Steiner, J D Quick
BMC Health Services Research|August 29, 2014
Quality use of medicines within universal health coverage: challenges and opportunitiesAnita K Wagner, Jonathan D Quick, Dennis Ross-Degnan
Lancet (London, England)|January 6, 1990
Drug economics in developing countriesJ I Litvack, D S Shepard, J D Quick
Pageof 11